US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 18, 2017 (9 years ago)

Saphris 10 mg (asenapine) sublingual tablets, 6x10 count blister packs, Rx only, Black…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling; Label Mixup; blister lidding foil and shell-pack labeled as 10 mg but package actually contains 5 mg tablets

What was recalled

Saphris 10 mg (asenapine) sublingual tablets, 6x10 count blister packs, Rx only, Black Cherry Flavor, Manufactured by: Catalent UK Swindon, Zydis Ltd, Blagrove, Swindon, Wilshire SN5 BRU, UK Distributed by Forest Pharmaceuticals, Inc. subsidiary of Forest Laboratories, LLC, Cincinnati OH 45209 USA --- NDC 0456-2410-60; Shellpack containing 1 blister card --- NDC 0456-2410-06

Recalling firm
Forest Laboratories, LLC
NDC code
0456-2410-60
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0880-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Pine recalls

See all